StonvexLoading…
StonvexStonvexStonvexCore line items from CGNX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $994.36M | $914.51M | $837.55M | $1.01B |
Operating Income | $162.57M | $115.06M | $130.70M | $246.23M |
Net Income | $114.44M | $106.17M | $113.23M | $215.53M |
EPS (Diluted) | $0.68 | $0.62 | $0.65 | $1.23 |
Total Assets | $2.02B | $1.99B | $2.02B | $1.96B |
Total Liabilities | $524.65M | $475.35M | $513.06M | $519.75M |
Cash & Equivalents | $262.93M | $186.09M | $202.66M | $181.37M |
Free Cash Flow OCF − CapEx | $236.77M | $134.04M | $89.84M | $223.74M |
Shares Outstanding | 167.00M | 170.43M | 171.60M | 172.63M |